Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Genetic risks to nicotine dependence predict negative mood and affect in current non-smokers.

Chen X, Aggen SH, Chen J, Li L, Kendler KS, Blank M, Eissenberg T.

Sci Rep. 2015 Mar 31;5:9521. doi: 10.1038/srep09521.

2.

Peer smoking and the nicotinic receptor genes: an examination of genetic and environmental risks for nicotine dependence.

Johnson EO, Chen LS, Breslau N, Hatsukami D, Robbins T, Saccone NL, Grucza RA, Bierut LJ.

Addiction. 2010 Nov;105(11):2014-22. doi: 10.1111/j.1360-0443.2010.03074.x. Epub 2010 Sep 15.

3.

[Association between nicotine dependence and the -521 promoter polymorfism of the dopamine D4 receptor in patients with major depression].

Kótyuk E, Kovács-Nagy R, Faludi G, Urbán R, Rónai Z, Sasvári-Székely M, Székely A.

Neuropsychopharmacol Hung. 2009 Jun;11(2):59-67. Hungarian.

4.

CYP2B6 gene single-nucleotide polymorphisms in an Italian population sample and relationship with nicotine dependence.

Riccardi LN, Carano F, Bini C, Ceccardi S, Ferri G, Pelotti S.

Genet Test Mol Biomarkers. 2015 Feb;19(2):103-7. doi: 10.1089/gtmb.2014.0239. Epub 2014 Dec 9.

PMID:
25489907
5.

Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies.

Nishizawa D, Kasai S, Hasegawa J, Sato N, Yamada H, Tanioka F, Nagashima M, Katoh R, Satoh Y, Tagami M, Ujike H, Ozaki N, Inada T, Iwata N, Sora I, Iyo M, Yamada M, Kondo N, Won MJ, Naruse N, Uehara-Aoyama K, Itokawa M, Ohi K, Hashimoto R, Tanisawa K, Arai T, Mori S, Sawabe M, Naka-Mieno M, Yamada Y, Yamada M, Sato N, Muramatsu M, Tanaka M, Irukayama-Tomobe Y, Saito YC, Sakurai T, Hayashida M, Sugimura H, Ikeda K.

Mol Brain. 2015 Aug 20;8:50. doi: 10.1186/s13041-015-0142-x.

6.

Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans.

Saccone NL, Schwantes-An TH, Wang JC, Grucza RA, Breslau N, Hatsukami D, Johnson EO, Rice JP, Goate AM, Bierut LJ.

Genes Brain Behav. 2010 Oct;9(7):741-50. doi: 10.1111/j.1601-183X.2010.00608.x. Epub 2010 Jul 22.

7.

Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes.

Saccone NL, Saccone SF, Hinrichs AL, Stitzel JA, Duan W, Pergadia ML, Agrawal A, Breslau N, Grucza RA, Hatsukami D, Johnson EO, Madden PA, Swan GE, Wang JC, Goate AM, Rice JP, Bierut LJ.

Am J Med Genet B Neuropsychiatr Genet. 2009 Jun 5;150B(4):453-66. doi: 10.1002/ajmg.b.30828.

8.

CHRNA5 variants moderate the effect of nicotine deprivation on a neural index of cognitive control.

Evans DE, MacQueen DA, Jentink KG, Park JY, Lin HY, Drobes DJ.

Genes Brain Behav. 2014 Sep;13(7):626-32. doi: 10.1111/gbb.12151. Epub 2014 Jul 23.

9.

Genetic polymorphisms in glutathione-S-transferases are associated with anxiety and mood disorders in nicotine dependence.

Odebrecht Vargas Nunes S, Pizzo de Castro MR, Ehara Watanabe MA, Losi Guembarovski R, Odebrecht Vargas H, Reiche EM, Kaminami Morimoto H, Dodd S, Berk M.

Psychiatr Genet. 2014 Jun;24(3):87-93. doi: 10.1097/YPG.0000000000000023.

10.

Initial reactions to tobacco and cannabis smoking: a twin study.

Agrawal A, Madden PA, Bucholz KK, Heath AC, Lynskey MT.

Addiction. 2014 Apr;109(4):663-71. doi: 10.1111/add.12449. Epub 2014 Jan 23.

11.

Pharmacotherapy and pharmacogenetics of nicotine dependence.

Berrettini WH, Lerman CE.

Am J Psychiatry. 2005 Aug;162(8):1441-51. Review.

PMID:
16055765
12.

A risk allele for nicotine dependence in CHRNA5 is a protective allele for cocaine dependence.

Grucza RA, Wang JC, Stitzel JA, Hinrichs AL, Saccone SF, Saccone NL, Bucholz KK, Cloninger CR, Neuman RJ, Budde JP, Fox L, Bertelsen S, Kramer J, Hesselbrock V, Tischfield J, Nurnberger JI Jr, Almasy L, Porjesz B, Kuperman S, Schuckit MA, Edenberg HJ, Rice JP, Goate AM, Bierut LJ.

Biol Psychiatry. 2008 Dec 1;64(11):922-9. doi: 10.1016/j.biopsych.2008.04.018. Epub 2008 Jun 2.

13.
14.

The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence.

Shiffman S, Waters A, Hickcox M.

Nicotine Tob Res. 2004 Apr;6(2):327-48.

PMID:
15203807
15.

The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans.

Saccone NL, Wang JC, Breslau N, Johnson EO, Hatsukami D, Saccone SF, Grucza RA, Sun L, Duan W, Budde J, Culverhouse RC, Fox L, Hinrichs AL, Steinbach JH, Wu M, Rice JP, Goate AM, Bierut LJ.

Cancer Res. 2009 Sep 1;69(17):6848-56. doi: 10.1158/0008-5472.CAN-09-0786. Epub 2009 Aug 25.

16.

Nicotine dependence, abuse and craving: dimensionality in an Israeli sample.

Shmulewitz D, Keyes KM, Wall MM, Aharonovich E, Aivadyan C, Greenstein E, Spivak B, Weizman A, Frisch A, Grant BF, Hasin D.

Addiction. 2011 Sep;106(9):1675-86. doi: 10.1111/j.1360-0443.2011.03484.x.

17.

Parental smoke exposure and the development of nicotine craving in adolescent novice smokers: the roles of DRD2, DRD4, and OPRM1 genotypes.

Kleinjan M, Engels RC, DiFranza JR.

BMC Pulm Med. 2015 Oct 8;15:115. doi: 10.1186/s12890-015-0114-z.

18.

Smoking and BDNF Val66Met polymorphism in male schizophrenia: a case-control study.

Zhang XY, Chen DC, Tan YL, Luo X, Zuo L, Lv MH, Shah NN, Zunta-Soares GB, Soares JC.

J Psychiatr Res. 2015 Jan;60:49-55. doi: 10.1016/j.jpsychires.2014.09.023. Epub 2014 Oct 8.

PMID:
25455509
19.

Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.

David SP, Johnstone EC, Murphy MF, Aveyard P, Guo B, Lerman C, Munafò MR.

Drug Alcohol Depend. 2008 Nov 1;98(1-2):77-85. doi: 10.1016/j.drugalcdep.2008.04.013. Epub 2008 Jun 17.

20.

Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women.

Janes AC, Smoller JW, David SP, Frederick BD, Haddad S, Basu A, Fava M, Evins AE, Kaufman MJ.

Drug Alcohol Depend. 2012 Jan 1;120(1-3):7-13. doi: 10.1016/j.drugalcdep.2011.06.009. Epub 2011 Jul 20.

Supplemental Content

Support Center